Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 852.9 Billion | USD 1962.538 Billion | 7.14 % | 2021 |
FrequentlyAsked Questions
Autologous chondrocyte implantation and Scaffolds implants are two of the most common therapies for osteoarthritis. As a result, demand for cartilage repair and regeneration products is predicted to rise as the prevalence of osteoarthritis rises.
According to the Market Research report, the global Cartilage Repair/Regeneration Market was worth around USD 852.9 million in 2021 and is estimated to grow to about USD 1962.538958 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.9 percent over the forecast period.
Due to the high prevalence of osteoarthritis, the growing prevalence of sports injuries, and increased research funding in the US and Canada, North America accounted for the highest proportion of the cartilage repair and regeneration market. Furthermore, increased physician and patient awareness of innovative treatment techniques and technologies, as well as considerable government investments in Cartilage Repair/Regeneration technologies and therapies, are all helping the market's growth in North America.
Some of the main competitors dominating the global cartilage repair/regeneration market include - DePuy Synthes (US), Smith & Nephew plc (UK), Zimmer Biomet (US), CONMED Corporation (US), Stryker Corporation (US), and Vericel Corporation (US).
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed